[EN] COMPOUNDS WHICH CAUSE DEGRADATION OF EGFR, FOR USE AGAINST CANCER<br/>[FR] COMPOSÉS QUI PROVOQUENT LA DÉGRADATION DE L'EGFR, DESTINÉS À ÊTRE UTILISÉS CONTRE LE CANCER
申请人:HOFFMANN LA ROCHE
公开号:WO2019149922A1
公开(公告)日:2019-08-08
Present invention provides compounds that cause specifically the degradation of EGFR via the targeted ubiquitination of EGFR protein and subsequent proteasomal degradation. The present compounds are useful for the treatment of various cancers.
本发明提供了一种通过靶向泛素化
EGFR蛋白并随后
蛋白酶体降解来特异性降解
EGFR的化合物。这些化合物可用于治疗各种癌症。